Autopsy report · NCT02454608

Trial of Verapamil in Chronic Rhinosinusitis

“Evidence that the dose is insufficient.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years before it stopped.
• 29 participants enrolled.
• Results were posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Benjamin Bleier

Sponsor type

University, hospital or other

Conditions

Sinusitis; Nasal Polyps

Interventions

Verapamil HCl; Placebo

Participants

29

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.